# DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer

> **NCT02504697** · — · ACTIVE_NOT_RECRUITING · sponsor: **Boston University** · enrollment: 665 (actual)

## Conditions studied

- Pulmonary Disease

## Interventions

- **OTHER:** Biosamples from airway and blood

## Key facts

- **NCT ID:** NCT02504697
- **Lead sponsor:** Boston University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2011-09
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 665 (ACTUAL)
- **Last updated:** 2026-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02504697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02504697, "DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02504697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*